HER-2/neu Oncogene Amplification by Chromogenic in situ Hybridization in 130 Breast Cancers Using Tissue Microarray and Clinical Follow-up Studies

Determining of HER-2/neu oncogene amplification has become clinically important for managing breast cancer. Fluorescent in situ hybridization (FISH) and immunohistochemistry (IHC) are currently regarded as the standard methods. Chromogenic in situ hybridization (CISH) was investigated as a new modif...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Eundeok, Lee, Anhi, Lee, Eunjung, Lee, Hekyung, Shin, Okran, Oh, Sejeong, Kang, Changsuk
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2004
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816840/
https://www.ncbi.nlm.nih.gov/pubmed/15201505
http://dx.doi.org/10.3346/jkms.2004.19.3.390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816840/
https://www.ncbi.nlm.nih.gov/pubmed/15201505
http://dx.doi.org/10.3346/jkms.2004.19.3.390

Ejemplares similares